In vivo imaging of neurotransmission and brain receptors in dementia (814 views) (PDF public 259 views)
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Research Support, Non-U. S. Gov'T, Review,
Impact factor: 1.811, 5-year impact factor: 1.872
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-41549129489&partnerID=40&md5=7717ddf10b1b9bc635a5068eb5ba8d6d
Keywords: Dementia, Neurochemical Imaging, Neurotransmission, Pet, Spect, Brain Receptor, Neurotransmitter, Alzheimer Disease, Cholinergic System, Differential Diagnosis, Dopaminergic System, Gabaergic System, Human, In Vivo Study, Neurochemistry, Neuroimaging, Nonhuman, Pathophysiology, Positron Emission Tomography, Review, Serotoninergic System, Single Photon Emission Computer Tomography, Neurotransmitter Agents, Radiopharmaceuticals, Emission-Computed, Single-Photon, Dementia Diagnostic Imaging Physiopathology , Neurotransmitter Agents Physiology , Emission-Computed Methods , Single-Photon Methods,
Affiliations:
*** IBB - CNR ***
Institute of Biostructure and Bioimaging, Department of Biomorphological Sciences, University Federico II, Naples, Italy
Department of Neurological Sciences, School of Biotechnological Sciences, University Federico II, Naples, Italy
Department of Clinical and Experimental Medicine, University Federico II, Naples, Italy
References:
Davies, P., Maloney, A.J., Selective loss of central cholinergic neurons in Alzheimer's disease (1976) Lancet, 2 (8000), p. 140
Francis, P.T., Palmer, A.M., Snape, M., Wilcock, G.K., The cholinergic hypothesis of Alzheimer's disease: A review of progress (1999) J Neurol Neurosurg Psychiatry, 66 (2), pp. 137-147
Volkow, N.D., Rosen, B., Farde, L., Imaging the living human brain: Magnetic resonance imaging and positron emission tomography (1997) Proc Natl Acad Sci USA, 94 (7), pp. 2787-2788
Minoshima, S., Frey, K.A., Cross, D.J., Kuhl, D.E., Neurochemical imaging of dementias (2004) Semin Nucl Med, 34 (1), pp. 70-82
Elsinga, P.H., Radiopharmaceutical chemistry for positron emission tomography (2002) Methods, 27, pp. 208-217
Slifstein, M., Laruelle, M., Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers (2001) Nucl Med Biol, 28, pp. 595-608
Laruelle, M., Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review (2000) J Cereb Blood Flow Metab, 20 (3), pp. 423-451
Nordberg, A., Neuroreceptor changes in Alzheimer disease (1992) Cerebrovasc Brain Metab Rev, 4 (4), pp. 303-328
Quarantelli, M., Berkouk, K., Prinster, A., Landeau, B., Svarer, C., Balkay, L., Alfano, B., Salvatore, M., Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction (2004) J Nucl Med, 45 (2), pp. 192-201
Sarter, M., Bruno, J.P., Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis (1997) Brain Res Brain Res Rev, 23 (1-2), pp. 28-46
Perry, E., Walker, M., Grace, J., Perry, R., Acetylcholine in mind: A neurotransmitter correlate of consciousness? (1999) Trends Neurosci, 22 (6), pp. 273-280
Bentley, P., Husain, M., Dolan, R.J., Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory (2004) Neuron, 41 (6), pp. 969-982
Geula, C., Mesulam, M.M., Cholinergic systems and related neuropathological predilection patterns in Alzheimer's disease (1994) Alzheimer's Disease., pp. 263-291. , In: Terry, R.D., Katzman, R., Bick, K.L., eds, New York: Raven Press
Ruberg, M., Rieger, F., Villageois, A., Bonnet, A.M., Agid, Y., Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease (1986) Brain Res, 362 (1), pp. 83-91
Perry, E.K., Haroutunian, V., Davis, K.L., Levy, R., Lantos, P., Eagger, S., Honavar, M., Perry, R.H., Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease (1994) Neuroreport, 5 (7), pp. 747-749
Warren, N.M., Piggott, M.A., Perry, E.K., Burn, D.J., Cholinergic systems in progressive supranuclear palsy (2005) Brain, 128 (2), pp. 239-249
Mesulam, M., Siddique, T., Cohen, B., Cholinergic denervation in a pure multi-infarct state: Observations on CADASIL (2003) Neurology, 60 (7), pp. 1183-1185
Kuhl, D.E., Koeppe, R.A., Fessler, J.A., Minoshima, S., Ackermann, R.J., Carey, J.E., Gildersleeve, D.L., Wieland, D.M., In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM (1994) J Nucl Med, 35 (3), pp. 405-410
Shinotoh, H., Fukushi, K., Nagatsuka, S., Irie, T., Acetylcholinesterase imaging: Its use in therapy evaluation and drug design (2004) Curr Pharm des, 10 (13), pp. 1505-1517
Atack, J.R., Perry, E.K., Bonham, J.R., Boakes, R., Candy, J.M., Loss and recovery of acetylcholinesterase molecular forms in the fornix-lesioned rat hippocampus (1987) Neurosci Lett, 79 (1-2), pp. 179-184
Fowler, J.S., Ding, Y.S., Volkow, N.D., Radiotracers for positron emission tomography imaging (2003) Semin Nucl Med, 33 (1), pp. 14-27
Kuhl, D.E., Minoshima, S., Fessler, J.A., Frey, K.A., Foster, N.L., Ficaro, E.P., Wieland, D.M., Koeppe, R.A., In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease (1996) Ann Neurol, 40 (3), pp. 399-410
Iyo, M., Namba, H., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., Sudo, Y., Irie, T., Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease (1997) Lancet, 349 (9068), pp. 1805-1809
Shinotoh, H., Namba, H., Fukushi, K., Nagatsuka, S., Tanaka, N., Aotsuka, A., Ota, T., Irie, T., Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study (2000) Ann Neurol, 48 (2), pp. 194-200
Herholz, K., Weisenbach, S., Zundorf, G., Lenz, O., Schroder, H., Bauer, B., Kalbe, E., Heiss, W.D., In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease (2004) Neuroimage, 21 (1), pp. 136-143
Rinne, J.O., Kaasinen, V., Jarvenpaa, T., Nagren, K., Roivainen, A., Yu, M., Oikonen, V., Kurki, T., Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease (2003) J Neurol Neurosurg Psychiatry, 74 (1), pp. 113-115
Bohnen, N.I., Kaufer, D.I., Ivanco, L.S., Lopresti, B., Koeppe, R.A., Davis, J.G., Mathis, C.A., Dekosky, S.T., Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study (2003) Arch Neurol, 60 (12), pp. 1745-1748
Eggers, C., Herholz, K., Kalbe, E., Heiss, W.D., Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease (2006) Neurosci Lett, 408 (1), pp. 46-50
Poirier, J., Delisle, M.C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Gauthier, S., Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease (1995) Proc Natl Acad Sci, 92 (26), pp. 12260-12264
Gsell, W., Strein, I., Riederer, P., The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared (1996) J Neural Transm Suppl, 47, pp. 73-101
Davis, K.L., Mohs, R.C., Marin, D., Purohit, D.P., Perl, D.P., Lantz, M., Austin, G., Haroutunian, V., Cholinergic markers in elderly patients with early signs of Alzheimer disease (1999) JAMA, 281 (15), pp. 1401-1406
Hu, L., Wong, T.P., Cote, S.L., Bell, K.F., Cuello, A.C., The impact of Abeta-plaques on cortical cholinergic and non-cholinergic pre-synaptic boutons in Alzheimer's disease-like transgenic mice (2003) Neuroscience, 121 (2), pp. 421-432
Shinotoh, H., Aotsuka, A., Fukushi, K., Nagatsuka, S., Tanaka, N., Ota, T., Tanada, S., Irie, T., Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET (2001) Neurology, 56 (3), pp. 408-410
Volkow, N.D., Ding, Y.S., Fowler, J.S., Gatley, S.J., Imaging brain cholinergic activity with positron emission tomography: Its role in the evaluation of cholinergic treatments in Alzheimer's dementia (2001) Biol Psychiatry, 49 (3), pp. 211-220
Flynn, D.D., Ferrari-Dileo, G., Mash, D.C., Levey, A.I., Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease (1995) J Neurochem, 64 (4), pp. 1888-1891
Kendziorra, K., Meyer, P., Wolf, H., Barthel, H., Hesse, S., Seese, A., Sorger, D., Sabri, O., Cerebral nicotinic acetylcholine receptors in patients with Alzheimer's disease assessed with 2-[18F]F-A85380 PET-correlations to dementia severity (2006) Neuroimage, 31 (2), pp. T39
O'Brien, J.T., Colloby, S.J., Pakrasi, S., Perry, E.K., Pimlott, S.L., Wyper, D.J., McKeith, I.G., Williams, E.D., Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography (2007) J Neurol Neurosurg Psychiatry, 78 (4), pp. 356-362
Pimlott, S.L., Piggott, M., Owens, J., Greally, E., Court, J.A., Jaros, E., Perry, R.H., Wyper, D., Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: In vitro binding study using 5-[(125)i]-a-85380 (2004) Neuropsychopharmacology, 29 (1), pp. 108-116
Hilker, R., Thomas, A.V., Klein, J.C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A.H., Heiss, W.D., Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways (2005) Neurology, 65 (11), pp. 1716-1722
Herholz, K., PET studies in dementia (2003) Ann Nucl Med, 17 (2), pp. 79-89
Hirano, S., Shinotoh, H., Kobayashi, T., Tsuboi, Y., Wszolek, Z.K., Aotsuka, A., Tanaka, N., Irie, T., Brain acetylcholinesterase activity in FTDP-17 studied by PET (2006) Neurology, 66 (8), pp. 1276-1277
Pappata, S., Traykov, L., Tavitian, B., Damier, P., Dubois, B., Jobert, A., Crouzel, C., Di Giamberardino, L., Striatal reduction of acetylcholinesterase (AChE) in patients with progressive supranuclear palsy (PSP) as measured by PET and 11C-physostigmine (11C-PHY) (1997) J Cereb Blood Flow and Metab, 17 (1), pp. S687
Pappata, S., Tavitian, B., Traykov, L., Jobert, A., Dalger, A., Mangin, J.F., Crouzel, C., Digiamberardino, L., In vivo imaging of human cerebral acetylcholinesterase (1996) J Neurochem, 67 (2), pp. 876-879
Emre, M., Dementia associated with Parkinson's disease (2003) Lancet Neurol, 2 (4), pp. 229-237
Farr, S.A., Flood, J.F., Morley, J.E., The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on post-trial memory processing in the hippocampus (2000) Neurobiol Learn Mem, 73 (2), pp. 150-167
Maubach, K., GABA(A) receptor subtype selective cognition enhancers (2003) Curr Drug Targets CNS Neurol Disord, 2 (4), pp. 233-239
Lanctot, K.L., Herrmann, N., Mazzotta, P., Khan, L.R., Ingber, N., GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behaviorial and psychological symptoms of dementia (2004) Can J Psychiatry, 49 (7), pp. 439-453
Beer, H.F., Bläuenstein, P.A., Hasler, P.H., Delaloye, B., Riccabona, G., Bangerl, I., Hunkeler, W., Schubiger, P.A., In vitro and in vivo evaluation of iodine-123-Ro 16-0154: A new imaging agent for SPECT investigations of benzodiazepine receptors (1990) J Nucl Med, 31 (6), pp. 1007-1014
Meyer, M., Koeppe, R.A., Frey, K.A., Foster, N.L., Kuhl, D.E., Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease (1995) Arch Neurol, 52 (3), pp. 314-317
Ohyama, M., Senda, M., Ishiwata, K., Kitamura, S., Mishina, M., Ishii, K., Toyama, H., Katayama, Y., Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF (1999) Ann Nucl Med, 13 (5), pp. 309-315
Soricelli, A., Postiglione, A., Grivet-Fojaja, M.R., Mainenti, P.P., Discepolo, A., Varrone, A., Salvatore, M., Lassen, N.A., Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (1996) Eur J Nucl Med, 23 (10), pp. 1323-1328
Fukuchi, K., Hashikawa, K., Seike, Y., Moriwaki, H., Oku, N., Ishida, M., Fujita, M., Nishimura, T., Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease (1997) J Nucl Med, 38 (3), pp. 467-470
Pappata, S., Varrone, A., Milan, G., Sansone, V., Iavarone, A., Panico, M.R., Quarantelli, M., Salvatore, M., SPECT study of GABAA/BZD receptors and cerebral blood flow in mild cognitive impairment (MCI) (2006) Neuroimage, 31 (2), pp. T169
Foster, N.L., Minoshima, S., Johanns, J., Little, R., Heumann, M.L., Kuhl, D.E., Gilman, S., PET measures of benzodiazepine receptors in progressive supranuclear palsy (2000) Neurology, 54 (9), pp. 1768-1773
Ihara, M., Tomimoto, H., Ishizu, K., Mukai, T., Yoshida, H., Sawamoto, N., Inoue, M., Fukuyama, H., Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study (2004) Stroke, 35 (4), pp. 942-947
Bell, K.F., Ducatenzeiler, A., Ribeiro-Da-Silva, A., Duff, K., Bennett, D.A., Claudio Cuello, A., The amyloid pathology progresses in a neurotransmitter-specific manner (2006) Neurobiol Aging, 27 (11), pp. 1644-1657
Hendricksen, M., Thomas, A.J., Ferrier, I.N., Ince, P., O'Brien, J.T., Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression (2004) Am J Psychiatry, 161 (6), pp. 1096-1102
Meltzer, C.C., Smith, G., Dekosky, S.T., Pollock, B.G., Mathis, C.A., Moore, R.Y., Kupfer, D.J., Reynolds III, C.F., Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging (1998) Neuropsychopharmacology, 18 (6), pp. 407-430
Huey, E.D., Putnam, K.T., Grafman, J., A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia (2006) Neurology, 66 (1), pp. 17-22
Blin, J., Baron, J.C., Dubois, B., Crouzel, C., Fiorelli, M., Attar-Levy, D., Pillon, B., Agid, Y., Loss of brain 5-HT2 receptors in Alzheimer's disease. in vivo assessment with positron emission tomography and [18F]setoperone (1993) Brain, 116 (3), pp. 497-510
Meltzer, C.C., Price, J.C., Mathis, C.A., Greer, P.J., Cantwell, M.N., Houck, P.R., Mulsant, B.H., Reynolds III, C.F., PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders (1999) Am J Psychiatry, 156 (12), pp. 1871-1878
Versijpt, J., Van Laere, K.J., Dumont, F., Decoo, D., Vandecapelle, M., Santens, P., Goethals, I., Korf, J., Imaging of the 5-HT2A system: Age-, gender-, and Alzheimer's disease-related findings (2003) Neurobiol Aging, 24 (4), pp. 553-561
Hasselbalch, S.G., Madsen, K., Svarer, C., Pinborg, L.H., Holm, S., Paulson, O.B., Waldemar, G., Knudsen, G.M., Reduced 5-HT(2A) receptor binding in patients with mild cognitive impairment (2007) Neurobiol Aging, , Jun 1. [Epub ahead of print]
Kepe, V., Barrio, J.R., Huang, S.C., Ercoli, L., Siddarth, P., Shoghi-Jadid, K., Cole, G.M., Phelps, M.E., Serotonin 1A receptors in the living brain of Alzheimer's disease patients (2006) Proc Natl Acad Sci, 103 (3), pp. 702-707
Franceschi, M., Anchisi, D., Pelati, O., Zuffi, M., Matarrese, M., Moresco, R.M., Fazio, F., Perani, D., Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration (2005) Ann Neurol, 57 (2), pp. 216-225
Robbins, T.W., Dopamine and cognition (2003) Curr Opin Neurol, 16 (2), pp. S1-S2
Piggott, M.A., Marshall, E.F., Thomas, N., Lloyd, S., Court, J.A., Jaros, E., Burn, D., Perry, E.K., Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution (1999) Brain, 122 (8), pp. 1449-1468
Pillon, B., Czernecki, V., Dubois, B., Dopamine and cognitive function (2003) Curr Opin Neurol, 16 (2), pp. S17-S22
Cropley, V.L., Fujita, M., Innis, R.B., Nathan, P.J., Molecular imaging of the dopaminergic system and its association with human cognitive function (2006) Biol Psychiatry, 59 (10), pp. 898-907
Marie, R.M., Barre, L., Dupuy, B., Viader, F., Defer, G., Baron, J.C., Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease (1999) Neurosci Lett, 260 (2), pp. 77-80
Cheesman, A.L., Barker, R.A., Lewis, S.J., Robbins, T.W., Owen, A.M., Brooks, D.J., Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease (2005) J Neurol Neurosurg Psychiatry, 76 (9), pp. 1204-1210
Rinne, J.O., Portin, R., Ruottinen, H., Nurmi, E., Bergman, J., Haaparanta, M., Solin, O., Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study (2000) Arch Neurol, 57 (4), pp. 470-475
Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y., Hatano, K., Brooks, D.J., Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study (2002) Brain, 125 (6), pp. 1358-1365
McKeith, I., Mintzer, J., Aarsland, D., Burn, D., Chiu, H., Cohen-Mansfield, J., Dickson, D., Reid, W., Dementia with Lewy bodies (2004) Lancet Neurol, 3 (1), pp. 19-28. , International Psychogeriatric Association Expert Meeting on DLB
Walker, Z., Costa, D.C., Walker, R.W., Shaw, K., Gacinovic, S., Stevens, T., Livingston, G., Katona, C.L., Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic pre-synaptic ligand (2002) J Neurol Neurosurg Psychiatry, 73 (2), pp. 134-140
Hu, X.S., Okamura, N., Arai, H., Higuchi, M., Matsui, T., Tashiro, M., Shinkawa, M., Sasaki, H., 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies (2000) Neurology, 55 (10), pp. 1575-1577
Colloby, S.J., O'Brien, J.T., Fenwick, J.D., Firbank, M.J., Burn, D.J., McKeith, I.G., Williams, E.D., The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease (2004) Neuroimage, 23 (3), pp. 956-966
Gilman, S., Koeppe, R.A., Little, R., An, H., Junck, L., Giordani, B., Persad, C., Wernette, K., Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease (2004) Ann Neurol, 55 (6), pp. 774-780
Walker, Z., Jaros, E., Walker, R.W., Lee, L., Costa, D.C., Livingston, G., Ince, P., Katona, C.L., Dementia with lewy bodies: A comparison of clinical diagnosis, FP-CIT SPECT imaging and autopsy (2007) J Neurol Neurosurg Psychiatry, , Mar 12. [Epub ahead of print]
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Reininger, C., Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study (2007) Lancet Neurol, 6 (4), pp. 305-313. , for the DLB Study Group
Colloby, S.J., Williams, E.D., Burn, D.J., Lloyd, J.J., McKeith, I.G., O'Brien, J.T., Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT (2005) Eur J Nucl Med Mol Imaging, 32 (10), pp. 1176-1185
Plotkin, M., Amthauer, H., Klaffke, S., Kuhn, A., Ludemann, L., Arnold, G., Wernecke, K.D., Venz, S., Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients (2005) J Neural Transm, 112 (5), pp. 677-692
Rinne, J.O., Sahlberg, N., Ruottinen, H., Nagren, K., Lehikoinen, P., Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography (1998) Neurology, 50 (1), pp. 152-156
Tyrrell, P.J., Sawle, G.V., Ibanez, V., Bloomfield, P.M., Leenders, K.L., Frackowiak, R.S., Rossor, M.N., Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type (1990) Arch Neurol, 47 (12), pp. 1318-1323
Pizzolato, G., Chierichetti, F., Fabbri, M., Cagnin, A., Dam, M., Ferlin, G., Battistin, L., Reduced striatal dopamine receptors in Alzheimer's disease: Single photon emission tomography study with the D2 tracer [123I]-IBZM (1996) Neurology, 47 (4), pp. 1065-1068
Kemppainen, N., Ruottinen, H., Nagren, K., Rinne, J.O., PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD (2000) Neurology, 55 (2), pp. 205-209
Meguro, K., Yamaguchi, S., Itoh, M., Fujiwara, T., Yamadori, A., Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: A double-tracer PET study (1997) Neurology, 49 (4), pp. 941-945
Tanaka, Y., Meguro, K., Yamaguchi, S., Ishii, H., Watanuki, S., Funaki, Y., Yamaguchi, K., Itoh, M., Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease (2003) Ann Nucl Med, 17 (7), pp. 567-573
Kemppainen, N., Laine, M., Laakso, M.P., Kaasinen, V., Nagren, K., Vahlberg, T., Kurki, T., Rinne, J.O., Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease (2003) Eur J Neurosci, 18 (1), pp. 149-154
Sperfeld, A.D., Collatz, M.B., Baier, H., Palmbach, M., Storch, A., Schwarz, J., Tatsch, K., Ludolph, A.C., FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation (1999) Ann Neurol, 46 (5), pp. 708-715
Pal, P.K., Wszolek, Z.K., Kishore, A., De La Fuente-Fernandez, R., Sossi, V., Uitti, R.J., Dobko, T., Stoessl, A.J., Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene) (2001) Parkinsonism Relat Disord, 7 (2), pp. 81-88
Rinne, J.O., Laine, M., Kaasinen, V., Norvasuo-Heila, M.K., Nagren, K., Helenius, H., Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia (2002) Neurology, 58 (10), pp. 1489-1493
Frisoni, G.B., Pizzolato, G., Bianchetti, A., Chierichetti, F., Ferlin, G., Battistin, L., Trabucchi, M., Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: Preliminary results (1994) Acta Neurol Scand, 89 (3), pp. 199-203
Baron, J.C., Maziere, B., Loc'H, C., Cambon, H., Sgouropoulos, P., Bonnet, A.M., Agid, Y., Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy (1986) J Cereb Blood Flow Metab, 6 (2), pp. 131-136
Brooks, D.J., PET studies in progressive supranuclear palsy (1994) J Neural Transm Suppl, 42, pp. 119-134
Ginovart, N., Lundin, A., Farde, L., Halldin, C., Backman, L., Swahn, C.G., Pauli, S., Sedvall, G., PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease (1997) Brain, 120, pp. 503-514
Lawrence, A.D., Weeks, R.A., Brooks, D.J., Andrews, T.C., Watkins, L.H., Harding, A.E., Robbins, T.W., Sahakian, B.J., The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease (1998) Brain, 121, pp. 1343-1355
Yoshita, M., Taki, J., Yokoyama, K., Noguchi-Shinohara, M., Matsumoto, Y., Nakajima, K., Yamada, M., Value of 123I-MIGB radioactivity in the differential diagnosis of DLB from AD (2006) Neurology, 66 (12), pp. 1850-1854
Pappata, S., Dehaene, S., Poline, J.B., Gregoire, M.C., Jobert, A., Delforge, J., Frouin, V., Syrota, A., In vivo detection of striatal dopamine release during reward: A PET study with [(11)C]raclopride and a single dynamic scan approach (2002) Neuroimage, 16 (4), pp. 1015-1027
Masters, C.L., Cappai, R., Barnham, K.J., Villemagne, V.L., Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics (2006) J Neurochem, 97 (6), pp. 1700-1725
Cagnin, A., Kassiou, M., Meikle, S.R., Banati, R.B., In vivo evidence for microglial activation in neurodegenerative dementia (2006) Acta Neurol Scand Suppl, 185, pp. 107-114
J Neuroimaging (ISSN: 1051-2284, 1051-2284linking), 2008 Apr; 18(2): 111-124.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Research Support, Non-U. S. Gov'T, Review,
Impact factor: 1.811, 5-year impact factor: 1.872
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-41549129489&partnerID=40&md5=7717ddf10b1b9bc635a5068eb5ba8d6d
Keywords: Dementia, Neurochemical Imaging, Neurotransmission, Pet, Spect, Brain Receptor, Neurotransmitter, Alzheimer Disease, Cholinergic System, Differential Diagnosis, Dopaminergic System, Gabaergic System, Human, In Vivo Study, Neurochemistry, Neuroimaging, Nonhuman, Pathophysiology, Positron Emission Tomography, Review, Serotoninergic System, Single Photon Emission Computer Tomography, Neurotransmitter Agents, Radiopharmaceuticals, Emission-Computed, Single-Photon, Dementia Diagnostic Imaging Physiopathology , Neurotransmitter Agents Physiology , Emission-Computed Methods , Single-Photon Methods,
Affiliations:
*** IBB - CNR ***
Institute of Biostructure and Bioimaging, Department of Biomorphological Sciences, University Federico II, Naples, Italy
Department of Neurological Sciences, School of Biotechnological Sciences, University Federico II, Naples, Italy
Department of Clinical and Experimental Medicine, University Federico II, Naples, Italy
References:
Davies, P., Maloney, A.J., Selective loss of central cholinergic neurons in Alzheimer's disease (1976) Lancet, 2 (8000), p. 140
Francis, P.T., Palmer, A.M., Snape, M., Wilcock, G.K., The cholinergic hypothesis of Alzheimer's disease: A review of progress (1999) J Neurol Neurosurg Psychiatry, 66 (2), pp. 137-147
Volkow, N.D., Rosen, B., Farde, L., Imaging the living human brain: Magnetic resonance imaging and positron emission tomography (1997) Proc Natl Acad Sci USA, 94 (7), pp. 2787-2788
Minoshima, S., Frey, K.A., Cross, D.J., Kuhl, D.E., Neurochemical imaging of dementias (2004) Semin Nucl Med, 34 (1), pp. 70-82
Elsinga, P.H., Radiopharmaceutical chemistry for positron emission tomography (2002) Methods, 27, pp. 208-217
Slifstein, M., Laruelle, M., Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers (2001) Nucl Med Biol, 28, pp. 595-608
Laruelle, M., Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review (2000) J Cereb Blood Flow Metab, 20 (3), pp. 423-451
Nordberg, A., Neuroreceptor changes in Alzheimer disease (1992) Cerebrovasc Brain Metab Rev, 4 (4), pp. 303-328
Quarantelli, M., Berkouk, K., Prinster, A., Landeau, B., Svarer, C., Balkay, L., Alfano, B., Salvatore, M., Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction (2004) J Nucl Med, 45 (2), pp. 192-201
Sarter, M., Bruno, J.P., Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis (1997) Brain Res Brain Res Rev, 23 (1-2), pp. 28-46
Perry, E., Walker, M., Grace, J., Perry, R., Acetylcholine in mind: A neurotransmitter correlate of consciousness? (1999) Trends Neurosci, 22 (6), pp. 273-280
Bentley, P., Husain, M., Dolan, R.J., Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory (2004) Neuron, 41 (6), pp. 969-982
Geula, C., Mesulam, M.M., Cholinergic systems and related neuropathological predilection patterns in Alzheimer's disease (1994) Alzheimer's Disease., pp. 263-291. , In: Terry, R.D., Katzman, R., Bick, K.L., eds, New York: Raven Press
Ruberg, M., Rieger, F., Villageois, A., Bonnet, A.M., Agid, Y., Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease (1986) Brain Res, 362 (1), pp. 83-91
Perry, E.K., Haroutunian, V., Davis, K.L., Levy, R., Lantos, P., Eagger, S., Honavar, M., Perry, R.H., Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease (1994) Neuroreport, 5 (7), pp. 747-749
Warren, N.M., Piggott, M.A., Perry, E.K., Burn, D.J., Cholinergic systems in progressive supranuclear palsy (2005) Brain, 128 (2), pp. 239-249
Mesulam, M., Siddique, T., Cohen, B., Cholinergic denervation in a pure multi-infarct state: Observations on CADASIL (2003) Neurology, 60 (7), pp. 1183-1185
Kuhl, D.E., Koeppe, R.A., Fessler, J.A., Minoshima, S., Ackermann, R.J., Carey, J.E., Gildersleeve, D.L., Wieland, D.M., In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM (1994) J Nucl Med, 35 (3), pp. 405-410
Shinotoh, H., Fukushi, K., Nagatsuka, S., Irie, T., Acetylcholinesterase imaging: Its use in therapy evaluation and drug design (2004) Curr Pharm des, 10 (13), pp. 1505-1517
Atack, J.R., Perry, E.K., Bonham, J.R., Boakes, R., Candy, J.M., Loss and recovery of acetylcholinesterase molecular forms in the fornix-lesioned rat hippocampus (1987) Neurosci Lett, 79 (1-2), pp. 179-184
Fowler, J.S., Ding, Y.S., Volkow, N.D., Radiotracers for positron emission tomography imaging (2003) Semin Nucl Med, 33 (1), pp. 14-27
Kuhl, D.E., Minoshima, S., Fessler, J.A., Frey, K.A., Foster, N.L., Ficaro, E.P., Wieland, D.M., Koeppe, R.A., In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease (1996) Ann Neurol, 40 (3), pp. 399-410
Iyo, M., Namba, H., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., Sudo, Y., Irie, T., Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease (1997) Lancet, 349 (9068), pp. 1805-1809
Shinotoh, H., Namba, H., Fukushi, K., Nagatsuka, S., Tanaka, N., Aotsuka, A., Ota, T., Irie, T., Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study (2000) Ann Neurol, 48 (2), pp. 194-200
Herholz, K., Weisenbach, S., Zundorf, G., Lenz, O., Schroder, H., Bauer, B., Kalbe, E., Heiss, W.D., In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease (2004) Neuroimage, 21 (1), pp. 136-143
Rinne, J.O., Kaasinen, V., Jarvenpaa, T., Nagren, K., Roivainen, A., Yu, M., Oikonen, V., Kurki, T., Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease (2003) J Neurol Neurosurg Psychiatry, 74 (1), pp. 113-115
Bohnen, N.I., Kaufer, D.I., Ivanco, L.S., Lopresti, B., Koeppe, R.A., Davis, J.G., Mathis, C.A., Dekosky, S.T., Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study (2003) Arch Neurol, 60 (12), pp. 1745-1748
Eggers, C., Herholz, K., Kalbe, E., Heiss, W.D., Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease (2006) Neurosci Lett, 408 (1), pp. 46-50
Poirier, J., Delisle, M.C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Gauthier, S., Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease (1995) Proc Natl Acad Sci, 92 (26), pp. 12260-12264
Gsell, W., Strein, I., Riederer, P., The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared (1996) J Neural Transm Suppl, 47, pp. 73-101
Davis, K.L., Mohs, R.C., Marin, D., Purohit, D.P., Perl, D.P., Lantz, M., Austin, G., Haroutunian, V., Cholinergic markers in elderly patients with early signs of Alzheimer disease (1999) JAMA, 281 (15), pp. 1401-1406
Hu, L., Wong, T.P., Cote, S.L., Bell, K.F., Cuello, A.C., The impact of Abeta-plaques on cortical cholinergic and non-cholinergic pre-synaptic boutons in Alzheimer's disease-like transgenic mice (2003) Neuroscience, 121 (2), pp. 421-432
Shinotoh, H., Aotsuka, A., Fukushi, K., Nagatsuka, S., Tanaka, N., Ota, T., Tanada, S., Irie, T., Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET (2001) Neurology, 56 (3), pp. 408-410
Volkow, N.D., Ding, Y.S., Fowler, J.S., Gatley, S.J., Imaging brain cholinergic activity with positron emission tomography: Its role in the evaluation of cholinergic treatments in Alzheimer's dementia (2001) Biol Psychiatry, 49 (3), pp. 211-220
Flynn, D.D., Ferrari-Dileo, G., Mash, D.C., Levey, A.I., Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease (1995) J Neurochem, 64 (4), pp. 1888-1891
Kendziorra, K., Meyer, P., Wolf, H., Barthel, H., Hesse, S., Seese, A., Sorger, D., Sabri, O., Cerebral nicotinic acetylcholine receptors in patients with Alzheimer's disease assessed with 2-[18F]F-A85380 PET-correlations to dementia severity (2006) Neuroimage, 31 (2), pp. T39
O'Brien, J.T., Colloby, S.J., Pakrasi, S., Perry, E.K., Pimlott, S.L., Wyper, D.J., McKeith, I.G., Williams, E.D., Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography (2007) J Neurol Neurosurg Psychiatry, 78 (4), pp. 356-362
Pimlott, S.L., Piggott, M., Owens, J., Greally, E., Court, J.A., Jaros, E., Perry, R.H., Wyper, D., Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: In vitro binding study using 5-[(125)i]-a-85380 (2004) Neuropsychopharmacology, 29 (1), pp. 108-116
Hilker, R., Thomas, A.V., Klein, J.C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A.H., Heiss, W.D., Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways (2005) Neurology, 65 (11), pp. 1716-1722
Herholz, K., PET studies in dementia (2003) Ann Nucl Med, 17 (2), pp. 79-89
Hirano, S., Shinotoh, H., Kobayashi, T., Tsuboi, Y., Wszolek, Z.K., Aotsuka, A., Tanaka, N., Irie, T., Brain acetylcholinesterase activity in FTDP-17 studied by PET (2006) Neurology, 66 (8), pp. 1276-1277
Pappata, S., Traykov, L., Tavitian, B., Damier, P., Dubois, B., Jobert, A., Crouzel, C., Di Giamberardino, L., Striatal reduction of acetylcholinesterase (AChE) in patients with progressive supranuclear palsy (PSP) as measured by PET and 11C-physostigmine (11C-PHY) (1997) J Cereb Blood Flow and Metab, 17 (1), pp. S687
Pappata, S., Tavitian, B., Traykov, L., Jobert, A., Dalger, A., Mangin, J.F., Crouzel, C., Digiamberardino, L., In vivo imaging of human cerebral acetylcholinesterase (1996) J Neurochem, 67 (2), pp. 876-879
Emre, M., Dementia associated with Parkinson's disease (2003) Lancet Neurol, 2 (4), pp. 229-237
Farr, S.A., Flood, J.F., Morley, J.E., The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on post-trial memory processing in the hippocampus (2000) Neurobiol Learn Mem, 73 (2), pp. 150-167
Maubach, K., GABA(A) receptor subtype selective cognition enhancers (2003) Curr Drug Targets CNS Neurol Disord, 2 (4), pp. 233-239
Lanctot, K.L., Herrmann, N., Mazzotta, P., Khan, L.R., Ingber, N., GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behaviorial and psychological symptoms of dementia (2004) Can J Psychiatry, 49 (7), pp. 439-453
Beer, H.F., Bläuenstein, P.A., Hasler, P.H., Delaloye, B., Riccabona, G., Bangerl, I., Hunkeler, W., Schubiger, P.A., In vitro and in vivo evaluation of iodine-123-Ro 16-0154: A new imaging agent for SPECT investigations of benzodiazepine receptors (1990) J Nucl Med, 31 (6), pp. 1007-1014
Meyer, M., Koeppe, R.A., Frey, K.A., Foster, N.L., Kuhl, D.E., Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease (1995) Arch Neurol, 52 (3), pp. 314-317
Ohyama, M., Senda, M., Ishiwata, K., Kitamura, S., Mishina, M., Ishii, K., Toyama, H., Katayama, Y., Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF (1999) Ann Nucl Med, 13 (5), pp. 309-315
Soricelli, A., Postiglione, A., Grivet-Fojaja, M.R., Mainenti, P.P., Discepolo, A., Varrone, A., Salvatore, M., Lassen, N.A., Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (1996) Eur J Nucl Med, 23 (10), pp. 1323-1328
Fukuchi, K., Hashikawa, K., Seike, Y., Moriwaki, H., Oku, N., Ishida, M., Fujita, M., Nishimura, T., Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease (1997) J Nucl Med, 38 (3), pp. 467-470
Pappata, S., Varrone, A., Milan, G., Sansone, V., Iavarone, A., Panico, M.R., Quarantelli, M., Salvatore, M., SPECT study of GABAA/BZD receptors and cerebral blood flow in mild cognitive impairment (MCI) (2006) Neuroimage, 31 (2), pp. T169
Foster, N.L., Minoshima, S., Johanns, J., Little, R., Heumann, M.L., Kuhl, D.E., Gilman, S., PET measures of benzodiazepine receptors in progressive supranuclear palsy (2000) Neurology, 54 (9), pp. 1768-1773
Ihara, M., Tomimoto, H., Ishizu, K., Mukai, T., Yoshida, H., Sawamoto, N., Inoue, M., Fukuyama, H., Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study (2004) Stroke, 35 (4), pp. 942-947
Bell, K.F., Ducatenzeiler, A., Ribeiro-Da-Silva, A., Duff, K., Bennett, D.A., Claudio Cuello, A., The amyloid pathology progresses in a neurotransmitter-specific manner (2006) Neurobiol Aging, 27 (11), pp. 1644-1657
Hendricksen, M., Thomas, A.J., Ferrier, I.N., Ince, P., O'Brien, J.T., Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression (2004) Am J Psychiatry, 161 (6), pp. 1096-1102
Meltzer, C.C., Smith, G., Dekosky, S.T., Pollock, B.G., Mathis, C.A., Moore, R.Y., Kupfer, D.J., Reynolds III, C.F., Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging (1998) Neuropsychopharmacology, 18 (6), pp. 407-430
Huey, E.D., Putnam, K.T., Grafman, J., A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia (2006) Neurology, 66 (1), pp. 17-22
Blin, J., Baron, J.C., Dubois, B., Crouzel, C., Fiorelli, M., Attar-Levy, D., Pillon, B., Agid, Y., Loss of brain 5-HT2 receptors in Alzheimer's disease. in vivo assessment with positron emission tomography and [18F]setoperone (1993) Brain, 116 (3), pp. 497-510
Meltzer, C.C., Price, J.C., Mathis, C.A., Greer, P.J., Cantwell, M.N., Houck, P.R., Mulsant, B.H., Reynolds III, C.F., PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders (1999) Am J Psychiatry, 156 (12), pp. 1871-1878
Versijpt, J., Van Laere, K.J., Dumont, F., Decoo, D., Vandecapelle, M., Santens, P., Goethals, I., Korf, J., Imaging of the 5-HT2A system: Age-, gender-, and Alzheimer's disease-related findings (2003) Neurobiol Aging, 24 (4), pp. 553-561
Hasselbalch, S.G., Madsen, K., Svarer, C., Pinborg, L.H., Holm, S., Paulson, O.B., Waldemar, G., Knudsen, G.M., Reduced 5-HT(2A) receptor binding in patients with mild cognitive impairment (2007) Neurobiol Aging, , Jun 1. [Epub ahead of print]
Kepe, V., Barrio, J.R., Huang, S.C., Ercoli, L., Siddarth, P., Shoghi-Jadid, K., Cole, G.M., Phelps, M.E., Serotonin 1A receptors in the living brain of Alzheimer's disease patients (2006) Proc Natl Acad Sci, 103 (3), pp. 702-707
Franceschi, M., Anchisi, D., Pelati, O., Zuffi, M., Matarrese, M., Moresco, R.M., Fazio, F., Perani, D., Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration (2005) Ann Neurol, 57 (2), pp. 216-225
Robbins, T.W., Dopamine and cognition (2003) Curr Opin Neurol, 16 (2), pp. S1-S2
Piggott, M.A., Marshall, E.F., Thomas, N., Lloyd, S., Court, J.A., Jaros, E., Burn, D., Perry, E.K., Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution (1999) Brain, 122 (8), pp. 1449-1468
Pillon, B., Czernecki, V., Dubois, B., Dopamine and cognitive function (2003) Curr Opin Neurol, 16 (2), pp. S17-S22
Cropley, V.L., Fujita, M., Innis, R.B., Nathan, P.J., Molecular imaging of the dopaminergic system and its association with human cognitive function (2006) Biol Psychiatry, 59 (10), pp. 898-907
Marie, R.M., Barre, L., Dupuy, B., Viader, F., Defer, G., Baron, J.C., Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease (1999) Neurosci Lett, 260 (2), pp. 77-80
Cheesman, A.L., Barker, R.A., Lewis, S.J., Robbins, T.W., Owen, A.M., Brooks, D.J., Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease (2005) J Neurol Neurosurg Psychiatry, 76 (9), pp. 1204-1210
Rinne, J.O., Portin, R., Ruottinen, H., Nurmi, E., Bergman, J., Haaparanta, M., Solin, O., Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study (2000) Arch Neurol, 57 (4), pp. 470-475
Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y., Hatano, K., Brooks, D.J., Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study (2002) Brain, 125 (6), pp. 1358-1365
McKeith, I., Mintzer, J., Aarsland, D., Burn, D., Chiu, H., Cohen-Mansfield, J., Dickson, D., Reid, W., Dementia with Lewy bodies (2004) Lancet Neurol, 3 (1), pp. 19-28. , International Psychogeriatric Association Expert Meeting on DLB
Walker, Z., Costa, D.C., Walker, R.W., Shaw, K., Gacinovic, S., Stevens, T., Livingston, G., Katona, C.L., Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic pre-synaptic ligand (2002) J Neurol Neurosurg Psychiatry, 73 (2), pp. 134-140
Hu, X.S., Okamura, N., Arai, H., Higuchi, M., Matsui, T., Tashiro, M., Shinkawa, M., Sasaki, H., 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies (2000) Neurology, 55 (10), pp. 1575-1577
Colloby, S.J., O'Brien, J.T., Fenwick, J.D., Firbank, M.J., Burn, D.J., McKeith, I.G., Williams, E.D., The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease (2004) Neuroimage, 23 (3), pp. 956-966
Gilman, S., Koeppe, R.A., Little, R., An, H., Junck, L., Giordani, B., Persad, C., Wernette, K., Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease (2004) Ann Neurol, 55 (6), pp. 774-780
Walker, Z., Jaros, E., Walker, R.W., Lee, L., Costa, D.C., Livingston, G., Ince, P., Katona, C.L., Dementia with lewy bodies: A comparison of clinical diagnosis, FP-CIT SPECT imaging and autopsy (2007) J Neurol Neurosurg Psychiatry, , Mar 12. [Epub ahead of print]
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Reininger, C., Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study (2007) Lancet Neurol, 6 (4), pp. 305-313. , for the DLB Study Group
Colloby, S.J., Williams, E.D., Burn, D.J., Lloyd, J.J., McKeith, I.G., O'Brien, J.T., Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT (2005) Eur J Nucl Med Mol Imaging, 32 (10), pp. 1176-1185
Plotkin, M., Amthauer, H., Klaffke, S., Kuhn, A., Ludemann, L., Arnold, G., Wernecke, K.D., Venz, S., Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients (2005) J Neural Transm, 112 (5), pp. 677-692
Rinne, J.O., Sahlberg, N., Ruottinen, H., Nagren, K., Lehikoinen, P., Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography (1998) Neurology, 50 (1), pp. 152-156
Tyrrell, P.J., Sawle, G.V., Ibanez, V., Bloomfield, P.M., Leenders, K.L., Frackowiak, R.S., Rossor, M.N., Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type (1990) Arch Neurol, 47 (12), pp. 1318-1323
Pizzolato, G., Chierichetti, F., Fabbri, M., Cagnin, A., Dam, M., Ferlin, G., Battistin, L., Reduced striatal dopamine receptors in Alzheimer's disease: Single photon emission tomography study with the D2 tracer [123I]-IBZM (1996) Neurology, 47 (4), pp. 1065-1068
Kemppainen, N., Ruottinen, H., Nagren, K., Rinne, J.O., PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD (2000) Neurology, 55 (2), pp. 205-209
Meguro, K., Yamaguchi, S., Itoh, M., Fujiwara, T., Yamadori, A., Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: A double-tracer PET study (1997) Neurology, 49 (4), pp. 941-945
Tanaka, Y., Meguro, K., Yamaguchi, S., Ishii, H., Watanuki, S., Funaki, Y., Yamaguchi, K., Itoh, M., Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease (2003) Ann Nucl Med, 17 (7), pp. 567-573
Kemppainen, N., Laine, M., Laakso, M.P., Kaasinen, V., Nagren, K., Vahlberg, T., Kurki, T., Rinne, J.O., Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease (2003) Eur J Neurosci, 18 (1), pp. 149-154
Sperfeld, A.D., Collatz, M.B., Baier, H., Palmbach, M., Storch, A., Schwarz, J., Tatsch, K., Ludolph, A.C., FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation (1999) Ann Neurol, 46 (5), pp. 708-715
Pal, P.K., Wszolek, Z.K., Kishore, A., De La Fuente-Fernandez, R., Sossi, V., Uitti, R.J., Dobko, T., Stoessl, A.J., Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene) (2001) Parkinsonism Relat Disord, 7 (2), pp. 81-88
Rinne, J.O., Laine, M., Kaasinen, V., Norvasuo-Heila, M.K., Nagren, K., Helenius, H., Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia (2002) Neurology, 58 (10), pp. 1489-1493
Frisoni, G.B., Pizzolato, G., Bianchetti, A., Chierichetti, F., Ferlin, G., Battistin, L., Trabucchi, M., Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: Preliminary results (1994) Acta Neurol Scand, 89 (3), pp. 199-203
Baron, J.C., Maziere, B., Loc'H, C., Cambon, H., Sgouropoulos, P., Bonnet, A.M., Agid, Y., Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy (1986) J Cereb Blood Flow Metab, 6 (2), pp. 131-136
Brooks, D.J., PET studies in progressive supranuclear palsy (1994) J Neural Transm Suppl, 42, pp. 119-134
Ginovart, N., Lundin, A., Farde, L., Halldin, C., Backman, L., Swahn, C.G., Pauli, S., Sedvall, G., PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease (1997) Brain, 120, pp. 503-514
Lawrence, A.D., Weeks, R.A., Brooks, D.J., Andrews, T.C., Watkins, L.H., Harding, A.E., Robbins, T.W., Sahakian, B.J., The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease (1998) Brain, 121, pp. 1343-1355
Yoshita, M., Taki, J., Yokoyama, K., Noguchi-Shinohara, M., Matsumoto, Y., Nakajima, K., Yamada, M., Value of 123I-MIGB radioactivity in the differential diagnosis of DLB from AD (2006) Neurology, 66 (12), pp. 1850-1854
Pappata, S., Dehaene, S., Poline, J.B., Gregoire, M.C., Jobert, A., Delforge, J., Frouin, V., Syrota, A., In vivo detection of striatal dopamine release during reward: A PET study with [(11)C]raclopride and a single dynamic scan approach (2002) Neuroimage, 16 (4), pp. 1015-1027
Masters, C.L., Cappai, R., Barnham, K.J., Villemagne, V.L., Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics (2006) J Neurochem, 97 (6), pp. 1700-1725
Cagnin, A., Kassiou, M., Meikle, S.R., Banati, R.B., In vivo evidence for microglial activation in neurodegenerative dementia (2006) Acta Neurol Scand Suppl, 185, pp. 107-114
In vivo imaging of neurotransmission and brain receptors in dementia
Positron emission tomography (PET) and single photon emission tomography (SPECT) are the most sensitive techniques to study, in vivo, neurotransmitter systems in normal human brain and in diseases. These methods have been applied over the last years to explore the integrity of cholinergic, serotonergic, GABAergic, and dopaminergic systems in Alzheimer's disease (AD) and in other dementias. The results of these investigations have provided new insights into the neurotransmission involvement in these disorders. Moreover, these methods provide objective quantitative markers for monitoring the progression of disease and the effects of therapies. The pathophysiological and clinical relevance of results from these studies are reviewed and the potential role in early and differential diagnosis discussed. New emerging radiotracers/methods for future investigations of neurochemical processes are delineated.
Positron emission tomography (PET) and single photon emission tomography (SPECT) are the most sensitive techniques to study, in vivo, neurotransmitter systems in normal human brain and in diseases. These methods have been applied over the last years to explore the integrity of cholinergic, serotonergic, GABAergic, and dopaminergic systems in Alzheimer's disease (AD) and in other dementias. The results of these investigations have provided new insights into the neurotransmission involvement in these disorders. Moreover, these methods provide objective quantitative markers for monitoring the progression of disease and the effects of therapies. The pathophysiological and clinical relevance of results from these studies are reviewed and the potential role in early and differential diagnosis discussed. New emerging radiotracers/methods for future investigations of neurochemical processes are delineated.
In vivo imaging of neurotransmission and brain receptors in dementia
| ▼ Relaxometry based MRI brain segmentation |
In vivo imaging of neurotransmission and brain receptors in dementia
Other filter: ([btitle,keywords] "Neurochemical Imagin ...
Allocca M, Linguanti F, Calcagni ML, Cistaro A, Gaudieri V, Guerra UP, Morbelli S, Nobili F, Pappata S, Sestini S, Volterrani D, Berti V, For The Neurology Study Group Of The Italian Association Of Nuclear M
* Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study (7 views)
J Clin Med (ISSN: 2077-0383linking), 2021 Oct 25; 10(21): N/D-N/D.
Impact Factor: 4.963
View Export to BibTeX Export to EndNote
Coppola C, Saracino D, Oliva M, Cipriano L, Puoti G, Pappata S, Di Fede G, Catania M, Ricci M, Cimini S, Giaccone G, Bonavita S, Rossi G
* Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances" (70 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2021 May; 42(5): 2021-2029.
Impact Factor: 1.447
View Export to BibTeX Export to EndNote
Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, Tedeschi G, Montella P, Milan G, Salvatore M, Salvatore E, Baron JC, Pappata S
* Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity (1309 views)
Neuroimage (ISSN: 1053-8119linking), 2018 Aug 1; 176: 246-258.
Impact Factor: 5.835
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (855 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Oliveri V, Zimbone S, Giuffrida ML, Bellia F, Tomasello MF, Vecchio G
* Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity (489 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(24): 6349-6353.
Impact Factor: 5.476
View Export to BibTeX Export to EndNote
Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (544 views)
Curr Opin Pharmacol (ISSN: 1471-4892), 2017 Dec 23; 38: 1-7.
Impact Factor: 6.313
View Export to BibTeX Export to EndNote
Sgarlata C, Arena G, Bonomo RP, Giuffrida A, Tabbì G
* Simple and mixed complexes of copper(II) with 8-hydroxyquinoline derivatives and amino acids: Characterization in solution and potential biological implications (411 views) (PDF 160 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2017 Dec 8; 180: 89-100.
Impact Factor: 3.063
View Export to BibTeX Export to EndNote
Zimbone S, Monaco I, Giani F, Pandini G, Copani AG, Giuffrida ML, Rizzarelli E
* Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells (727 views) (PDF 197 views)
Aging Cell (ISSN: 1474-9726, 1474-9718linking), 2017 Nov 01; 17(1): N/D-N/D.
Impact Factor: 7.627
View Export to BibTeX Export to EndNote
Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (291 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2017 Mar 15; 115: 180-192.
Impact Factor: 5.012
View Export to BibTeX Export to EndNote
Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, Rossi M, Di Costanzo A
* Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis? (350 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2017; 60(3): 1097-1106.
Impact Factor: 3.476
View Export to BibTeX Export to EndNote
D'Andrea LD, Rosa LD, Vigliotti C, Cataldi M
* VEGF mimic peptides: Potential applications in central nervous system therapeutics (787 views)
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A
* Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons (527 views)
Front Cell Neurosci (ISSN: 1662-5102), 2015 Aug 7; 9(AUGUST): 297-297.
Impact Factor: 4.609
View Export to BibTeX Export to EndNote
Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (806 views)
Eur J Pharmacol (ISSN: 0014-2999), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
View Export to BibTeX Export to EndNote
Giacomelli C, Trincavelli ML, Satriano C, Hansson O, La Mendola D, Rizzarelli E, Martini C
* Copper (II) ions modulate Angiogenin activity in human endothelial cells (424 views)
Int J Biochem Cell B (ISSN: 1357-2725), 2015 Mar; 60: 185-196.
Impact Factor: 3.905
View Export to BibTeX Export to EndNote
Merlo S, Basile L, Giuffrida ML, Sortino MA, Guccione S, Copani A
* Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity (323 views)
J Nat Prod (ISSN: 0163-3864), 2015; 78(11): 2704-2711.
Impact Factor: 3.662
View Export to BibTeX Export to EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (433 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (518 views)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
View Export to BibTeX Export to EndNote
Testi S, Peluso S, Fabrizi GM, Antenora A, Russo CV, Pappata S, Padovani A, Ferrarini M, Filla A
* A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia (289 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2014; 41(3): 709-714.
Impact Factor: 4.151
View Export to BibTeX Export to EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (541 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Attanasio F, Convertino M, Magno A, Caflisch A, Corazza A, Haridas H, Esposito G, Cataldo S, Pignataro B, Milardi D, Rizzarelli E
* Carnosine Inhibits Abeta(42) Aggregation By Perturbing The H-Bond Network In And Around The Central Hydrophobic Cluster (838 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2013 Mar 18; 14(5): 583-592.
Impact Factor: 3.06
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A
* Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease (1536 views)
Mol Neurobiol (ISSN: 0893-7648), 2012 Dec; 46(3): 605-613.
Impact Factor: 5.471
View Export to BibTeX Export to EndNote
Grasso G, Salomone F, Tundo GR, Pappalardo G, Ciaccio C, Spoto G, Pietropaolo A, Coletta M, Rizzarelli E
* Metal ions affect insulin-degrading enzyme activity (495 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Dec; 117: 351-358.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Forestier A, Douki T, Sauvaigo S, De Rosa V, Demeilliers C, Rachidi W
* Alzheimer's disease-associated neurotoxic peptide amyloid-beta impairs base excision repair in human neuroblastoma cells (461 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2012 Nov 13; 13(11): 14766-14787.
Impact Factor: 2.464
View Export to BibTeX Export to EndNote
Pascual B, Prieto E, Arbizu J, Marti-climent JM, Penuelas I, Quincoces G, Zarauza R, Pappata S, Masdeu JC
* Decreased carbon-11-flumazenil binding in early Alzheimer's disease (405 views) (PDF 259 views)
Brain (ISSN: 0006-8950, 1460-2156electronic, 0006-8950linking), 2012 Sep; 135(Pt9): 2817-2825.
Impact Factor: 9.915
View Export to BibTeX Export to EndNote
Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
* Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (647 views)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Impact Factor: 2.659
View Export to BibTeX Export to EndNote
Grasso G, Giuffrida ML, Rizzarelli E
* Metallostasis And Amyloid Beta-Degrading Enzymes (1035 views)
Metallomics (ISSN: 1756-5901, 1756-591x, 1756-591xelectronic), 2012 Sep; 4(9): 937-949.
Impact Factor: 4.099
View Export to BibTeX Export to EndNote
Travaglia A, Pietropaolo A, La Mendola D, Nicoletti VG, Rizzarelli E
* The inorganic perspectives of neurotrophins and Alzheimer's disease (609 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Jun; 111: 130-137.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (1289 views)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (900 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (492 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Damante CA, Ösz K, Nagy Z, Grasso G, Pappalardo G, Rizzarelli E, Sóvágó I
* Zn2+'s ability to alter the distribution of Cu2+ among the available binding sites of A beta(1-16)-polyethylenglycol-ylated peptide: Implications in Alzheimer's disease (531 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2011 Jun 20; 50(12): 5342-5350.
Impact Factor: 4.601
View Export to BibTeX Export to EndNote
Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (596 views)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
View Export to BibTeX Export to EndNote
Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
* Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice (612 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2011 Mar 15; 6(3): e17971-e17971.
Impact Factor: 4.092
View Export to BibTeX Export to EndNote
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (765 views)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
View Export to BibTeX Export to EndNote
Grasso G, Pietropaolo A, Spoto G, Pappalardo G, Tundo GR, Ciaccio C, Coletta M, Rizzarelli E
* Copper(I) and Copper(II) Inhibit A beta Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer's Disease (576 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2011 Feb 25; 17(9): 2752-2762.
Impact Factor: 5.925
View Export to BibTeX Export to EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (542 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
View Export to BibTeX Export to EndNote
Cervenka S, Varrone A, Fransen E, Halldin C, Farde L
* PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans (553 views)
Synapse (ISSN: 0887-4476), 2010 Jun; 64(6): 478-485.
Impact Factor: 2.925
View Export to BibTeX Export to EndNote
Pappata S, Varrone A, Vicidomini C, Milan G, De Falco C, Sansone V, Iavarone A, Comerci M, Loré E, Panico M, Quarantelli M, Postiglione A, Salvatore M
* SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment (504 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jun; 37(6): 1156-1163.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G
* Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation (1002 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806.
Impact Factor: 8.017
View Export to BibTeX Export to EndNote
Darcourt J, Booij J, Tatsch K, Varrone A, Borght TV, Kapucu OL, Nagren K, Nobili F, Walker Z, Van Laere K
* EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version (766 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Feb; 37(2): 443-450.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
D'Antò V, Michelotti A, Esposito L, Zagari A, Liguori R, Sacchetti L
* Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder (362 views)
J Sci Med Sport (ISSN: 1440-2440), 2010; 13(6): 174-179.
Impact Factor: 3.194
View Export to BibTeX Export to EndNote
Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (681 views)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (581 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (635 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (1121 views)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864, 1523-0864linking), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
View Export to BibTeX Export to EndNote
Arnesano F, Scintilla S, Calò V, Bonfrate E, Ingrosso C, Losacco M, Pellegrino T, Rizzarelli E, Natile G
* Copper-triggered aggregation of ubiquitin (534 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2009 Sep 16; 4(9): e7052-e7052.
Impact Factor: 4.351
View Export to BibTeX Export to EndNote
Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (358 views)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (1402 views)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
Milan G, Lamenza F, Iavarone A, Galeone F, Lore E, De Falco C, Sorrentino P, Postiglione A
* Frontal Behavioural Inventory in the differential diagnosis of dementia (644 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2008; 117(4): 260-265.
Impact Factor: 2.317
View Export to BibTeX Export to EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (454 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (1010 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Copani A, Caraci F, Hoozemans J, Calafiore M, Sortino M, Nicoletti F
* The nature of the cell cycle in neurons: Focus on a "non-canonical" pathway of DNA replication causally related to death (517 views)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2007 Apr; 1772(4): 409-412.
Impact Factor: 3.078
View Export to BibTeX Export to EndNote
Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E
* Abeta(25-35) And Its C- And/Or N-Blocked Derivatives: Copper Driven Structural Features And Neurotoxicity (629 views)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Feb 15; 85(3): 623-633.
Impact Factor: 3.268
View Export to BibTeX Export to EndNote
Serrano CM, Allegri RF, Caramelli P, Taragano FE, Camera L
* Mild cognitive impairment. Survey of attitudes of specialists and general physicians (618 views)
Medicina (ISSN: 0025-7680), 2007; 67(1): 19-25.
Impact Factor: 0.193
View Export to BibTeX Export to EndNote
Bosco P, Caraci F, Copani A, Spada R, Sortino M, Salluzzo R, Salemi M, Nicoletti F, Ferri R
* The CDC2 I-G-T haplotype associated with the APOE ε4 allele increases the risk of sporadic Alzheimer's disease in Sicily (376 views)
Neurosci Lett (ISSN: 0304-3940), 2007; 419(3): 195-198.
Impact Factor: 2.085
View Export to BibTeX Export to EndNote
Esposito L, Pedone C, Vitagliano L
* Molecular dynamics analyses of cross-beta-spine steric zipper models: beta-sheet twisting and aggregation (768 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2006 Sep 1; 103(31): 11533-11538.
Impact Factor: 9.643
View Export to BibTeX Export to EndNote
Copani A, Hoozemans JJM, Caraci F, Calafiore M, Van Haastert ES, Veerhuis R, Rozemuller AJM, Aronica E, Sortino MA, Nicoletti F
* Dna Polymerase-Beta Is Expressed Early In Neurons Of Alzheimer'S Disease Brain And Is Loaded Into Dna Replication Forks In Neurons Challenged With Beta-Amyloid (504 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2006; 26(43): 10949-10957.
Impact Factor: 2.117
View Export to BibTeX Export to EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (585 views)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
View Export to BibTeX Export to EndNote
Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (808 views)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
View Export to BibTeX Export to EndNote
Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC, Nicoletti F
* Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain (553 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2004 Jun 30; 24(26): 6021-6027.
Impact Factor: 2.384
View Export to BibTeX Export to EndNote
Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D
* Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide Aβ1-42 by mirror image phage display (722 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2003; 4(8): 748-753.
Impact Factor: 3.992
View Export to BibTeX Export to EndNote
Varrone A, Pappata S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M
* Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks (474 views) (PDF 309 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2002 Nov; 29(11): 1447-1454.
Impact Factor: 3.568
View Export to BibTeX Export to EndNote
Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A
* Absolute quantification by positron emission tomography of the endogenous ligand (344 views)
J Cereb Blood Flow Metab (ISSN: 0271-678x), 2001 May; 21(5): 613-630.
Impact Factor: 5.477
View Export to BibTeX Export to EndNote
Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B
Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies (641 views) (PDF 272 views)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic), 2000 Mar; 11(3): 260-266.
Impact Factor: 1.302
View Export to BibTeX Export to EndNote
Varrone A, Soricelli A, Postiglione A, Salvatore M
Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT (315 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1999 Sep; 24(9): 660-665.
Impact Factor: 0.253
View Export to BibTeX Export to EndNote
Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (617 views) (PDF 596 views)
Magn Reson Med (ISSN: 0740-3194, 1522-2594electronic, 0740-3194linking), 1998 Mar; 39(3): 497-499.
Impact Factor: 2.962
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli A, Grossi D, Romano M, Mainenti PP, Ruocco A, Fragrassi N, Chiacchio L, Milan G, De Chiara S, Brunetti A
Changes in cerebral blood flow during cognitive activation evaluated by single photon emission computed tomography in patients with Alzheimer's disease (449 views)
Alzheimer S Res (ISSN: 1356-918x), 1997 Jun; 3(3): 93-99.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli, Salvatore M, Lassen NA
123I-iomazenil as a clinical tool for studying neuronal loss [4] (340 views)
J Am Geriatr Soc (ISSN: 0002-8614), 1997 Apr; 45(4): 534-536.
Impact Factor: 2.806
View Export to BibTeX Export to EndNote
Soricelli A, Varrone A, Acampa W, Postiglione A, Salvatore M, Lassen N
Brain perfusion with Tc-99m HMPAO and neuronal loss with 123-iomazenil in Alzheimer disease (323 views)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 1996 Nov; 201: N/D-N/D.
Impact Factor: 4.989
View Export to BibTeX Export to EndNote
Soricelli A, Postiglione A, GrivetFojaja M, Mainenti PP, Discepolo A, Varrone A, Salvatore M, Lassen N
Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (417 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1996 Oct; 23(10): 1323-1328.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
* Evaluation of Age and Sex-Related Metabolic Changes in Healthy Subjects: An Italian Brain 18F-FDG PET Study (7 views)
J Clin Med (ISSN: 2077-0383linking), 2021 Oct 25; 10(21): N/D-N/D.
Impact Factor: 4.963
View Export to BibTeX Export to EndNote
Coppola C, Saracino D, Oliva M, Cipriano L, Puoti G, Pappata S, Di Fede G, Catania M, Ricci M, Cimini S, Giaccone G, Bonavita S, Rossi G
* Singular cases of Alzheimer's disease disclose new and old genetic "acquaintances" (70 views)
Neurol Sci (ISSN: 1590-1874linking, 1590-3478), 2021 May; 42(5): 2021-2029.
Impact Factor: 1.447
View Export to BibTeX Export to EndNote
Marchitelli R, Aiello M, Cachia A, Quarantelli M, Cavaliere C, Postiglione A, Tedeschi G, Montella P, Milan G, Salvatore M, Salvatore E, Baron JC, Pappata S
* Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity (1309 views)
Neuroimage (ISSN: 1053-8119linking), 2018 Aug 1; 176: 246-258.
Impact Factor: 5.835
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (855 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Oliveri V, Zimbone S, Giuffrida ML, Bellia F, Tomasello MF, Vecchio G
* Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity (489 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(24): 6349-6353.
Impact Factor: 5.476
View Export to BibTeX Export to EndNote
Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (544 views)
Curr Opin Pharmacol (ISSN: 1471-4892), 2017 Dec 23; 38: 1-7.
Impact Factor: 6.313
View Export to BibTeX Export to EndNote
Sgarlata C, Arena G, Bonomo RP, Giuffrida A, Tabbì G
* Simple and mixed complexes of copper(II) with 8-hydroxyquinoline derivatives and amino acids: Characterization in solution and potential biological implications (411 views) (PDF 160 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2017 Dec 8; 180: 89-100.
Impact Factor: 3.063
View Export to BibTeX Export to EndNote
Zimbone S, Monaco I, Giani F, Pandini G, Copani AG, Giuffrida ML, Rizzarelli E
* Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells (727 views) (PDF 197 views)
Aging Cell (ISSN: 1474-9726, 1474-9718linking), 2017 Nov 01; 17(1): N/D-N/D.
Impact Factor: 7.627
View Export to BibTeX Export to EndNote
Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (291 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2017 Mar 15; 115: 180-192.
Impact Factor: 5.012
View Export to BibTeX Export to EndNote
Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, Rossi M, Di Costanzo A
* Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis? (350 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2017; 60(3): 1097-1106.
Impact Factor: 3.476
View Export to BibTeX Export to EndNote
D'Andrea LD, Rosa LD, Vigliotti C, Cataldi M
* VEGF mimic peptides: Potential applications in central nervous system therapeutics (787 views)
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A
* Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons (527 views)
Front Cell Neurosci (ISSN: 1662-5102), 2015 Aug 7; 9(AUGUST): 297-297.
Impact Factor: 4.609
View Export to BibTeX Export to EndNote
Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (806 views)
Eur J Pharmacol (ISSN: 0014-2999), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
View Export to BibTeX Export to EndNote
Giacomelli C, Trincavelli ML, Satriano C, Hansson O, La Mendola D, Rizzarelli E, Martini C
* Copper (II) ions modulate Angiogenin activity in human endothelial cells (424 views)
Int J Biochem Cell B (ISSN: 1357-2725), 2015 Mar; 60: 185-196.
Impact Factor: 3.905
View Export to BibTeX Export to EndNote
Merlo S, Basile L, Giuffrida ML, Sortino MA, Guccione S, Copani A
* Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity (323 views)
J Nat Prod (ISSN: 0163-3864), 2015; 78(11): 2704-2711.
Impact Factor: 3.662
View Export to BibTeX Export to EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (433 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappata S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L; EADC-PET Consortium
* Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting (518 views)
Neuroimage Clin (ISSN: 2213-1582, 2213-1582electronic, 2213-1582linking), 2014 Oct 24; 6: 445-454.
Impact Factor: 2.526
View Export to BibTeX Export to EndNote
Testi S, Peluso S, Fabrizi GM, Antenora A, Russo CV, Pappata S, Padovani A, Ferrarini M, Filla A
* A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia (289 views)
J Alzheimers Dis (ISSN: 1387-2877, 1387-2877linking), 2014; 41(3): 709-714.
Impact Factor: 4.151
View Export to BibTeX Export to EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (541 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Attanasio F, Convertino M, Magno A, Caflisch A, Corazza A, Haridas H, Esposito G, Cataldo S, Pignataro B, Milardi D, Rizzarelli E
* Carnosine Inhibits Abeta(42) Aggregation By Perturbing The H-Bond Network In And Around The Central Hydrophobic Cluster (838 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2013 Mar 18; 14(5): 583-592.
Impact Factor: 3.06
View Export to BibTeX Export to EndNote
Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A
* Beta-Amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease (1536 views)
Mol Neurobiol (ISSN: 0893-7648), 2012 Dec; 46(3): 605-613.
Impact Factor: 5.471
View Export to BibTeX Export to EndNote
Grasso G, Salomone F, Tundo GR, Pappalardo G, Ciaccio C, Spoto G, Pietropaolo A, Coletta M, Rizzarelli E
* Metal ions affect insulin-degrading enzyme activity (495 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Dec; 117: 351-358.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Forestier A, Douki T, Sauvaigo S, De Rosa V, Demeilliers C, Rachidi W
* Alzheimer's disease-associated neurotoxic peptide amyloid-beta impairs base excision repair in human neuroblastoma cells (461 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2012 Nov 13; 13(11): 14766-14787.
Impact Factor: 2.464
View Export to BibTeX Export to EndNote
Pascual B, Prieto E, Arbizu J, Marti-climent JM, Penuelas I, Quincoces G, Zarauza R, Pappata S, Masdeu JC
* Decreased carbon-11-flumazenil binding in early Alzheimer's disease (405 views) (PDF 259 views)
Brain (ISSN: 0006-8950, 1460-2156electronic, 0006-8950linking), 2012 Sep; 135(Pt9): 2817-2825.
Impact Factor: 9.915
View Export to BibTeX Export to EndNote
Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
* Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (647 views)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Impact Factor: 2.659
View Export to BibTeX Export to EndNote
Grasso G, Giuffrida ML, Rizzarelli E
* Metallostasis And Amyloid Beta-Degrading Enzymes (1035 views)
Metallomics (ISSN: 1756-5901, 1756-591x, 1756-591xelectronic), 2012 Sep; 4(9): 937-949.
Impact Factor: 4.099
View Export to BibTeX Export to EndNote
Travaglia A, Pietropaolo A, La Mendola D, Nicoletti VG, Rizzarelli E
* The inorganic perspectives of neurotrophins and Alzheimer's disease (609 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2012 Jun; 111: 130-137.
Impact Factor: 3.197
View Export to BibTeX Export to EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (1289 views)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (900 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (492 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Damante CA, Ösz K, Nagy Z, Grasso G, Pappalardo G, Rizzarelli E, Sóvágó I
* Zn2+'s ability to alter the distribution of Cu2+ among the available binding sites of A beta(1-16)-polyethylenglycol-ylated peptide: Implications in Alzheimer's disease (531 views)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2011 Jun 20; 50(12): 5342-5350.
Impact Factor: 4.601
View Export to BibTeX Export to EndNote
Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (596 views)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
View Export to BibTeX Export to EndNote
Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
* Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice (612 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2011 Mar 15; 6(3): e17971-e17971.
Impact Factor: 4.092
View Export to BibTeX Export to EndNote
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (765 views)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
View Export to BibTeX Export to EndNote
Grasso G, Pietropaolo A, Spoto G, Pappalardo G, Tundo GR, Ciaccio C, Coletta M, Rizzarelli E
* Copper(I) and Copper(II) Inhibit A beta Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer's Disease (576 views)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2011 Feb 25; 17(9): 2752-2762.
Impact Factor: 5.925
View Export to BibTeX Export to EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (542 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
View Export to BibTeX Export to EndNote
Cervenka S, Varrone A, Fransen E, Halldin C, Farde L
* PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans (553 views)
Synapse (ISSN: 0887-4476), 2010 Jun; 64(6): 478-485.
Impact Factor: 2.925
View Export to BibTeX Export to EndNote
Pappata S, Varrone A, Vicidomini C, Milan G, De Falco C, Sansone V, Iavarone A, Comerci M, Loré E, Panico M, Quarantelli M, Postiglione A, Salvatore M
* SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment (504 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jun; 37(6): 1156-1163.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G
* Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation (1002 views)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806.
Impact Factor: 8.017
View Export to BibTeX Export to EndNote
Darcourt J, Booij J, Tatsch K, Varrone A, Borght TV, Kapucu OL, Nagren K, Nobili F, Walker Z, Van Laere K
* EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version (766 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Feb; 37(2): 443-450.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
D'Antò V, Michelotti A, Esposito L, Zagari A, Liguori R, Sacchetti L
* Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder (362 views)
J Sci Med Sport (ISSN: 1440-2440), 2010; 13(6): 174-179.
Impact Factor: 3.194
View Export to BibTeX Export to EndNote
Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (681 views)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (581 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K
* EANM procedure guidelines for PET brain imaging using [18F]FDG, version (635 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2103-2110.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (1121 views)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864, 1523-0864linking), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
View Export to BibTeX Export to EndNote
Arnesano F, Scintilla S, Calò V, Bonfrate E, Ingrosso C, Losacco M, Pellegrino T, Rizzarelli E, Natile G
* Copper-triggered aggregation of ubiquitin (534 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2009 Sep 16; 4(9): e7052-e7052.
Impact Factor: 4.351
View Export to BibTeX Export to EndNote
Vergote J, Chalon S, Emond P, Vercouillie J, Pappata S, Guilloteau D
* New SPECT and PET dementia tracers (358 views)
Med Nucl (ISSN: 0928-1258), 2009 Mar; 33(3): 137-141.
Impact Factor: 0.155
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (1402 views)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
Milan G, Lamenza F, Iavarone A, Galeone F, Lore E, De Falco C, Sorrentino P, Postiglione A
* Frontal Behavioural Inventory in the differential diagnosis of dementia (644 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2008; 117(4): 260-265.
Impact Factor: 2.317
View Export to BibTeX Export to EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (454 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (1010 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Copani A, Caraci F, Hoozemans J, Calafiore M, Sortino M, Nicoletti F
* The nature of the cell cycle in neurons: Focus on a "non-canonical" pathway of DNA replication causally related to death (517 views)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2007 Apr; 1772(4): 409-412.
Impact Factor: 3.078
View Export to BibTeX Export to EndNote
Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E
* Abeta(25-35) And Its C- And/Or N-Blocked Derivatives: Copper Driven Structural Features And Neurotoxicity (629 views)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Feb 15; 85(3): 623-633.
Impact Factor: 3.268
View Export to BibTeX Export to EndNote
Serrano CM, Allegri RF, Caramelli P, Taragano FE, Camera L
* Mild cognitive impairment. Survey of attitudes of specialists and general physicians (618 views)
Medicina (ISSN: 0025-7680), 2007; 67(1): 19-25.
Impact Factor: 0.193
View Export to BibTeX Export to EndNote
Bosco P, Caraci F, Copani A, Spada R, Sortino M, Salluzzo R, Salemi M, Nicoletti F, Ferri R
* The CDC2 I-G-T haplotype associated with the APOE ε4 allele increases the risk of sporadic Alzheimer's disease in Sicily (376 views)
Neurosci Lett (ISSN: 0304-3940), 2007; 419(3): 195-198.
Impact Factor: 2.085
View Export to BibTeX Export to EndNote
Esposito L, Pedone C, Vitagliano L
* Molecular dynamics analyses of cross-beta-spine steric zipper models: beta-sheet twisting and aggregation (768 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2006 Sep 1; 103(31): 11533-11538.
Impact Factor: 9.643
View Export to BibTeX Export to EndNote
Copani A, Hoozemans JJM, Caraci F, Calafiore M, Van Haastert ES, Veerhuis R, Rozemuller AJM, Aronica E, Sortino MA, Nicoletti F
* Dna Polymerase-Beta Is Expressed Early In Neurons Of Alzheimer'S Disease Brain And Is Loaded Into Dna Replication Forks In Neurons Challenged With Beta-Amyloid (504 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2006; 26(43): 10949-10957.
Impact Factor: 2.117
View Export to BibTeX Export to EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (585 views)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
View Export to BibTeX Export to EndNote
Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (808 views)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
View Export to BibTeX Export to EndNote
Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC, Nicoletti F
* Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain (553 views)
J Neurosci (ISSN: 0270-6474, 0361-803x, 1529-2401), 2004 Jun 30; 24(26): 6021-6027.
Impact Factor: 2.384
View Export to BibTeX Export to EndNote
Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D
* Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide Aβ1-42 by mirror image phage display (722 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2003; 4(8): 748-753.
Impact Factor: 3.992
View Export to BibTeX Export to EndNote
Varrone A, Pappata S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M
* Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks (474 views) (PDF 309 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2002 Nov; 29(11): 1447-1454.
Impact Factor: 3.568
View Export to BibTeX Export to EndNote
Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A
* Absolute quantification by positron emission tomography of the endogenous ligand (344 views)
J Cereb Blood Flow Metab (ISSN: 0271-678x), 2001 May; 21(5): 613-630.
Impact Factor: 5.477
View Export to BibTeX Export to EndNote
Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B
Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies (641 views) (PDF 272 views)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic), 2000 Mar; 11(3): 260-266.
Impact Factor: 1.302
View Export to BibTeX Export to EndNote
Varrone A, Soricelli A, Postiglione A, Salvatore M
Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT (315 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1999 Sep; 24(9): 660-665.
Impact Factor: 0.253
View Export to BibTeX Export to EndNote
Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (617 views) (PDF 596 views)
Magn Reson Med (ISSN: 0740-3194, 1522-2594electronic, 0740-3194linking), 1998 Mar; 39(3): 497-499.
Impact Factor: 2.962
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli A, Grossi D, Romano M, Mainenti PP, Ruocco A, Fragrassi N, Chiacchio L, Milan G, De Chiara S, Brunetti A
Changes in cerebral blood flow during cognitive activation evaluated by single photon emission computed tomography in patients with Alzheimer's disease (449 views)
Alzheimer S Res (ISSN: 1356-918x), 1997 Jun; 3(3): 93-99.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Postiglione A, Soricelli, Salvatore M, Lassen NA
123I-iomazenil as a clinical tool for studying neuronal loss [4] (340 views)
J Am Geriatr Soc (ISSN: 0002-8614), 1997 Apr; 45(4): 534-536.
Impact Factor: 2.806
View Export to BibTeX Export to EndNote
Soricelli A, Varrone A, Acampa W, Postiglione A, Salvatore M, Lassen N
Brain perfusion with Tc-99m HMPAO and neuronal loss with 123-iomazenil in Alzheimer disease (323 views)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 1996 Nov; 201: N/D-N/D.
Impact Factor: 4.989
View Export to BibTeX Export to EndNote
Soricelli A, Postiglione A, GrivetFojaja M, Mainenti PP, Discepolo A, Varrone A, Salvatore M, Lassen N
Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (417 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1996 Oct; 23(10): 1323-1328.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
70 Records (67 excluding Abstracts).
Total impact factor: 303.684 (290.252 excluding Abstracts).
Total 5 year impact factor: 315.774 (300.579 excluding Abstracts).
Total impact factor: 303.684 (290.252 excluding Abstracts).
Total 5 year impact factor: 315.774 (300.579 excluding Abstracts).
814 views. Last view on Wednesday 07 June 2023, 3:19:14
ibb.cnr.it
